Current Affairs - Science
Why should I study the current affairs questions and answers section on "Science" daily?
Read the daily current affairs questions and answers section on "Science" to enhance your general knowledge for clearing competitive examinations and placement interviews.
Where can I get the current affairs questions and answers section on "Science"?
IndiaBIX provides you with daily current affairs questions and answers with explanations.
Where can I get the current affairs MCQ questions and answers section on "Science" (objective type, multiple choice)?
Here you can find multiple-choice-type current affairs questions and answers on "Science" for your interviews and competitive examinations. All the CA questions are arranged in different categories, including date-wise.
How do I download the current affairs questions section on "Science" in PDF format?
You can download the current affairs quiz questions and answers section on "Science" as PDF files or eBooks.
How do I answer the current affairs quiz section on "Science"?
You can answer any current affairs quiz question on "Science" by reading this current affairs section daily.
Exercise : Science - Latest Current Affairs
- Science - Latest Current Affairs
1.
What percentage of Indian women aged 25-49 have undergone hysterectomy, according to NFHS-4?
Answer: Option
Explanation:
NFHS-4 data reveals that approximately 5% of Indian women aged 25-49 have undergone hysterectomy, with heavy menstrual bleeding being a major cause. The study analyzed data from over 4.5 lakh women across rural and urban areas during 2015-16. Published in the Journal of Medical Evidence, it highlighted a 4.8% prevalence of hysterectomy in this demographic. This insight underscores the need for further research into women’s health and access to alternative treatments.
Date : 2025-01-06
2.
What is the name of the injectable HIV prevention drug expected to reach low-income countries by 2025?
Answer: Option
Explanation:
Lenacapavir is an injectable HIV prevention drug targeted for availability in low-income countries by 2025, pending regulatory approvals from the FDA and WHO. It is currently used in the U.S. for drug-resistant HIV but at a high cost. Collaborative efforts by organizations like the Global Fund and PEPFAR aim to make it affordable and accessible in resource-limited settings.
Date : 2024-12-18
3.
In which city has India’s first diabetes biobank been established?
Answer: Option
Explanation:
India’s first diabetes biobank has been set up in Chennai through a collaboration between the Indian Council of Medical Research (ICMR) and the Madras Diabetes Research Foundation (MDRF). The facility is designed to collect, process, and store biological samples, aiding advanced research on diabetes causes, variations, and related disorders. The biobank will support critical studies like the ICMR-INDIAB study and the Registry of Young-Onset Diabetes. It aims to identify biomarkers for early diagnosis and develop personalized treatment strategies, fostering long-term research on diabetes progression, management, and prevention, while also contributing to global health research efforts.
Date : 2024-12-16
4.
What is the name of the initiative launched by Northern Coalfields Limited (NCL) to provide free treatment for life-threatening diseases?
Answer: Option
Explanation:
Northern Coalfields Limited (NCL), under the Ministry of Coal, launched the ‘CHARAK’ initiative—Community Health: A Responsive Action for Koylanchal—to provide free treatment for life-threatening diseases. This initiative targets economically weaker residents of Singrauli and Sonbhadra districts with annual family incomes below Rs. 8 lakh. CHARAK covers treatment for conditions like malignancy, TB, cardiovascular diseases, HIV, neurological disorders, and more. Free treatment is provided at NCL’s hospital or specialized empanelled hospitals nationwide. This project highlights NCL’s continued focus on corporate social responsibility (CSR), particularly in healthcare, aiming to improve the well-being of vulnerable communities.
Date : 2024-12-16
5.
What is the name of India’s first indigenous macrolide antibiotic?
Answer: Option
Explanation:
Nafithromycin is India’s first homegrown macrolide antibiotic, marking a significant milestone in combating antimicrobial resistance (AMR). AMR poses a severe global health threat, contributing to 6 lakh deaths annually in India alone. Developed after 30 years of research, Nafithromycin received ₹8 crore funding from BIRAC under the Biotech Industry Program for Phase 3 trials. This innovation highlights India's progress in antibiotic development and its commitment to addressing the AMR crisis.
Date : 2024-12-07
Quick links
Quantitative Aptitude
Verbal (English)
Reasoning
Programming
Interview
Placement Papers